GAUDIO, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 1.306
AS - Asia 808
EU - Europa 368
SA - Sud America 113
Continente sconosciuto - Info sul continente non disponibili 75
AF - Africa 63
OC - Oceania 2
Totale 2.735
Nazione #
US - Stati Uniti d'America 1.267
SG - Singapore 334
CN - Cina 299
IT - Italia 134
DE - Germania 104
BR - Brasile 84
MA - Marocco 51
VN - Vietnam 50
FR - Francia 33
PK - Pakistan 27
BD - Bangladesh 21
HK - Hong Kong 21
IN - India 18
GB - Regno Unito 16
CA - Canada 15
NL - Olanda 12
MX - Messico 11
PL - Polonia 11
AR - Argentina 8
ES - Italia 8
JP - Giappone 8
EC - Ecuador 7
FI - Finlandia 7
ID - Indonesia 7
UA - Ucraina 6
ZA - Sudafrica 6
AT - Austria 4
BZ - Belize 4
EE - Estonia 4
IE - Irlanda 4
RU - Federazione Russa 4
SE - Svezia 4
TR - Turchia 4
AE - Emirati Arabi Uniti 3
BE - Belgio 3
CL - Cile 3
CO - Colombia 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
EG - Egitto 3
JM - Giamaica 3
VE - Venezuela 3
AU - Australia 2
BG - Bulgaria 2
HU - Ungheria 2
IQ - Iraq 2
KG - Kirghizistan 2
KR - Corea 2
LV - Lettonia 2
PE - Perù 2
UZ - Uzbekistan 2
AZ - Azerbaigian 1
BO - Bolivia 1
DZ - Algeria 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
GY - Guiana 1
HR - Croazia 1
IL - Israele 1
IS - Islanda 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
LT - Lituania 1
MD - Moldavia 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SV - El Salvador 1
UY - Uruguay 1
Totale 2.660
Città #
San Jose 185
Dallas 163
Singapore 157
Ashburn 148
Frankfurt am Main 77
The Dalles 68
Chandler 61
Beijing 54
Hefei 54
Casablanca 50
San Francisco 48
Council Bluffs 38
Los Angeles 29
New York 26
Hong Kong 21
Bari 19
Santa Clara 19
Phoenix 18
Boardman 17
Islamabad 16
Hillsboro 14
Columbus 13
Hanoi 12
Ho Chi Minh City 12
Munich 12
Bitonto 11
Milan 11
Atlanta 10
Princeton 10
Warsaw 10
Chicago 9
Lawrence 9
Modugno 9
Orem 9
Legnago 8
Chardon 7
Chennai 7
London 7
Molfetta 7
Boston 6
Boydton 6
Da Nang 6
Helsinki 6
Montreal 6
Oxnard 6
Reston 6
São Paulo 6
Amsterdam 5
Cranberry Township 5
Marseille 5
Mexico City 5
Nuremberg 5
Tokyo 5
Casamassima 4
Guayaquil 4
Newark 4
Rome 4
Seattle 4
Stockholm 4
Brooklyn 3
Brussels 3
Buffalo 3
Cairo 3
Curitiba 3
Johannesburg 3
Kolkata 3
Mammelzen 3
Milwaukee 3
New Orleans 3
Scordia 3
Toronto 3
Adelfia 2
Belo Horizonte 2
Bishkek 2
Cincinnati 2
Cleveland 2
Denver 2
Dubai 2
Dublin 2
Durban 2
Foggia 2
Haiphong 2
Houston 2
Ikegami 2
Kansas City 2
Kingston 2
Las Vegas 2
Lima 2
Lomas de Zamora 2
Miami 2
Montalto Uffugo 2
Naples 2
New Delhi 2
Ninh Bình 2
Odesa 2
Osasco 2
Padua 2
Palm Bay 2
Prague 2
Quito 2
Totale 1.651
Nome #
Diffuse Large B Cell Lymphoma Arising in Patients with Preexisting Hodgkin Lymphoma 72
Different patterns of mast cell distribution in B-cell non-Hodgkin lymphomas 63
The Anti-Metastatic Role of Aspirin in Cancer: A Systematic Review 62
Different spatial distribution of inflammatory cells in the tumor microenvironment of ABC and GBC subgroups of diffuse large B cell lymphoma 62
Blastic Plasmocytoid Dendritic Cell Neoplasm (BPDCN): Clinical Features and Histopathology with a Therapeutic Overview 61
Tumor cell microenvironment and microvessel density analysis in MALT type lymphoma 61
Brentuximab vedotin as salvage treatment in Hodgkin lymphoma naïve transplant patients or failing ASCT: the real life experience of Rete Ematologica Pugliese (REP) 59
STAT-3 RNAscope Determination in Human Diffuse Large B-Cell Lymphoma 59
The Effect of the Tumor Microenvironment on Lymphoid Neoplasms Derived from B Cells 59
Inflammatory Cells in Diffuse Large B Cell Lymphoma 57
STAT3, tumor microenvironment, and microvessel density in diffuse large B cell lymphomas 55
STAT3, tumor microenvironment, and microvessel density in diffuse large B cell lymphomas 55
Computer-driven quantitative image analysis in the assessment of tumor cell and T cell features in diffuse large B cell lymphomas 54
Molecular Features and Diagnostic Challenges in Alpha/Beta T-Cell Large Granular Lymphocyte Leukemia 53
CT-guided needle biopsy performed with modified coaxial technique in patients with refractory or recurrent lymphomas 52
Long-Term Breast Cancer Risk in Hodgkin Lymphoma Survivors: Evaluating Background Parenchymal Enhancement and Radiotherapy-Induced Toxicity 52
BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients 51
High Ki67 index and bulky disease remain significant adverse prognostic factors in patients with diffuse large B cell lymphoma before and after the introduction of rituximab 51
The Evolving Role of Cannabidiol-Rich Cannabis in People with Autism Spectrum Disorder: A Systematic Review 49
Plerixafor in association with R-DHAP and G-CSF to mobilize a large number of CD34 + cells in patients with relapsed-refractory diffuse large B-cell lymphomas 48
STAT-3 RNAscope Determination in Human Diffuse Large B-Cell Lymphoma 48
Bone Involvement in Hodgkin's Lymphoma: Clinical Features and Outcome 47
Sequencing Anti-CD19 Therapies in Diffuse Large B-Cell Lymphoma: From Mechanistic Insights to Clinical Strategies 46
Computed tomography-guided needle biopsy performed with modified coaxial technique in patients with suspected lymphoma 45
Brentuximab vedotin prior to allogeneic stem cell transplantation increases survival in chemorefractory Hodgkin's lymphoma patients 45
CD3+/Tregs ratio in donor grafts is linked to acute graft-versus-host disease and immunologic recovery after allogeneic peripheral blood stem cell transplantation 44
Italian real life experience with brentuximab vedotin: results of a large observational study on 234 relapsed/refractory Hodgkin's lymphoma 44
Checkpoint Inhibition Followed by CAR-T Cell Therapy in Refractory PMLBCL: Immunologic Response and Fertility Preservation in a Young Patient 44
The Tumor Microenvironment in Classic Hodgkin’s Lymphoma in Responder and No-Responder Patients to First Line ABVD Therapy 42
Long-term Hodgkin Lymphoma Survivors: A Glimpse of What Happens 10 Years After Treatment 41
Extralymphatic Disease Is an Independent Prognostic Factor in Hodgkin Lymphoma 41
CT-guided needle biopsy performed with modified coaxial technique in the diagnosis of malignant lymphomas 41
Bendamustine, etoposide, cytarabine, melphalan, and autologous stem cell rescue produce a 72% 3-year PFS in resistant lymphoma 40
Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a retrospective analysis 39
Intravascular Lymphoma: A Unique Pattern Underlying a Protean Disease 39
The Role of Peptides in Nutrition: Insights into Metabolic, Musculoskeletal, and Behavioral Health: A Systematic Review 38
Outcome of Very Late Relapse in Patients with Hodgkin's Lymphomas 38
Outcomes of Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Hodgkin Lymphomas: A Retrospective Multicenter Experience by the Rete Ematologica Pugliese (REP) 36
The Tumor Microenvironment in Classic Hodgkin’s Lymphoma in Responder and No-Responder Patients to First Line ABVD Therapy 36
Prognostic Role of CDKN2A Deletion and p53 Expression and Association With MIPIb in Mantle Cell Lymphoma 36
The Tumor Microenvironment in Classic Hodgkin's Lymphoma in Responder and No-Responder Patients to First Line ABVD Therapy 35
Recovery of CMV-specific CD8(+) T cells and T regs after allogeneic peripheral blood stem cell transplantation 35
Relapsing/refractory HL After Autotransplantation: Which Treatment? 35
Long-term Hodgkin Lymphoma Survivors: A Glimpse of What Happens 10 Years After Treatment 34
Lenalidomide in Pretreated Patients with Diffuse Large B-Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice 34
Tumor Microenvironment and Microvascular Density in Follicular Lymphoma 34
T cells, mast cells and microvascular density in diffuse large B cell lymphoma 33
Peripheral blood CD4/CD19 cell ratio is an independent prognostic factor in classical Hodgkin lymphoma 33
Pregnancy rate and outcome of pregnancies in long-term survivors of Hodgkin's lymphoma 32
Lenalidomide Combination Therapy in Relapsed/Refractory Diffuse Large B Cell Lymphoma: The Italian Real-Life Experience 32
Romidepsin in relapsed/refractory T-cell lymphomas: Italian experience and results of a named patient program 32
Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma 32
Breast Cancer Risk After Chest Radiotherapy in Hodgkin Lymphoma Survivors: A Comprehensive Overview 32
STAT3, tumor microenvironment, and microvessel density in diffuse large B cell lymphomas 32
Impact of Hematopoietic Stem Cell Transplantation on PD-1 Blockade Efficacy in Relapsed/Refractory Hodgkin’s Lymphoma 31
Poor mobilization is an independent prognostic factor in patients with malignant lymphomas treated by peripheral blood stem cell transplantation 31
Subsets of CD34+ and early engraftment kinetics in allogeneic peripheral SCT for AML 29
Mobilization of peripheral blood stem cells with high-dose cyclophosphamide or the DHAP regimen plus G-CSF in non-Hodgkin's lymphoma 28
Genetic Alterations in Multiple Myeloma: Implications for Prognosis and Advances in Diagnostic Approaches 27
Risk of lymphoma subtypes by occupational exposure in southern Italy 27
Microvascular density, CD68 and tryptase expression in human diffuse large B-cell lymphoma 26
Outcome of allogeneic peripheral blood stem cell transplantation by donor graft CD3+/Tregs ratio: a single-center experience 26
STAT-3 RNAscope Determination in Human Diffuse Large B-Cell Lymphoma 23
Hybrid Systems for Post-Stroke Upper-Limb Rehabilitation: Current Trends and Future Perspectives 20
Mechanisms of Action of Ready-to-Use Therapies in Hematologic Malignancies: From Clinical Impact to Future Directions 19
Targeting the Tumor Microenvironment in Hodgkin Lymphoma: Challenges and Therapeutic Strategies 18
Totale 2.735
Categoria #
all - tutte 25.117
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.117


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202227 0 0 0 0 0 0 7 0 8 10 1 1
2022/2023134 18 0 0 24 13 24 0 10 30 1 14 0
2023/2024107 5 4 2 3 5 1 2 2 8 49 5 21
2024/2025402 6 20 17 21 40 81 12 31 55 17 63 39
2025/20261.736 56 198 123 257 89 66 313 160 142 201 81 50
2026/2027329 43 47 121 118 0 0 0 0 0 0 0 0
Totale 2.735